Want to see JP:4882 full AI Analyst Report?
4882 Stock Chart & Stats
¥220.00
-¥14.00(-2.34%)
At close: 4:00 PM EST
¥220.00
-¥14.00(-2.34%)
Day’s Range― - ―
52-Week Range¥134.00 - ¥414.00
Previous CloseN/A
Volume686.20K
Average Volume (3M)226.58K
Market Cap
¥2.62B
Enterprise Value¥608.57M
Total Cash (Recent Filing)¥1.52B
Total Debt (Recent Filing)¥0.00
Price to Earnings (P/E)―
Beta2.18
Next Earnings
Aug 13, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-48.18
Shares Outstanding18,429,500
10 Day Avg. Volume184,610
30 Day Avg. Volume226,583
Financial Highlights & Ratios
PEG Ratio0.19
Price to Book (P/B)2.69
Price to Sales (P/S)24.20
P/FCF Ratio-4.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-62.5
Revenue Forecast (FY)¥120.00M
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthConsistent multi-year revenue expansion demonstrates durable commercial traction and market adoption of products. Steady top-line growth increases the potential to scale operating leverage and supports long-term investment in R&D and commercial channels if losses are brought under control.
No Reported Debt (conservative Leverage)A debt-free balance sheet reduces default and liquidity risk, giving management flexibility on capital structure and strategic choices. This preserves optionality for financing future growth through equity or partnerships rather than servicing interest, a durable advantage during cash burn phases.
High Gross ProfitabilityStrong gross margins indicate the core product economics are favorable and scalable. If operating expenses are controlled, high gross profitability provides a structural path to sustainable operating profit as revenue scales and absorption of fixed costs improves over the medium term.
Bears Say
Large Persistent Operating LossesChronic, sizable operating losses materially erode capital and signal the business is not yet earning a return on sales. Over months, ongoing losses force reliance on external capital, reduce strategic flexibility, and increase risk that future growth will not translate into sustainable profitability.
Chronic Negative Free Cash FlowPersistent negative free cash flow indicates the company consumes cash to run operations and capex. Even with modest improvement, sustained burn requires frequent financings, which can dilute shareholders and constrain long-term investments if funding terms become unfavorable.
Eroding Shareholder EquityMaterial decline in equity over several years reflects cumulative losses and value dilution, weakening the company’s capital base. This long-term erosion impairs resilience to shocks, increases reliance on external funding, and can limit strategic options such as M&A or large-scale commercialization.
Perseus Proteomics, Inc. News
4882 FAQ
What was Perseus Proteomics, Inc.’s price range in the past 12 months?
Perseus Proteomics, Inc. lowest stock price was ¥134.00 and its highest was ¥414.00 in the past 12 months.
What is Perseus Proteomics, Inc.’s market cap?
Perseus Proteomics, Inc.’s market cap is ¥2.62B.
When is Perseus Proteomics, Inc.’s upcoming earnings report date?
Perseus Proteomics, Inc.’s upcoming earnings report date is Aug 13, 2026 which is tomorrow.
How were Perseus Proteomics, Inc.’s earnings last quarter?
Perseus Proteomics, Inc. released its earnings results on May 14, 2026. The company reported -¥11.03 earnings per share for the quarter, missing the consensus estimate of N/A by -¥11.03.
Is Perseus Proteomics, Inc. overvalued?
According to Wall Street analysts Perseus Proteomics, Inc.’s price is currently Overvalued.
Does Perseus Proteomics, Inc. pay dividends?
Perseus Proteomics, Inc. does not currently pay dividends.
What is Perseus Proteomics, Inc.’s EPS estimate?
Perseus Proteomics, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Perseus Proteomics, Inc. have?
Perseus Proteomics, Inc. has 18,429,500 shares outstanding.
What happened to Perseus Proteomics, Inc.’s price movement after its last earnings report?
Perseus Proteomics, Inc. reported an EPS of -¥11.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.047%.
Which hedge fund is a major shareholder of Perseus Proteomics, Inc.?
Currently, no hedge funds are holding shares in JP:4882
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Perseus Proteomics, Inc.
null
Technical Analysis
Trans Genic Inc.
―
Cosmo Bio Co., Ltd.
―
ReproCELL Inc.
―
Human Metabolome Technologies, Inc.
―
Precision System Science Co.,Ltd
―